Meridian Bioscience Announces Better-than-expected Preliminary First Quarter Fiscal 2021 Revenue Results
CINCINNATI, Jan. 07, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of diagnostic testing solutions and life science raw materials, announced preliminary financial results for the first quarter of fiscal 2021. Preliminary First Quarter Fiscal 2021 Results The Company expects first quarter of fiscal 2021 revenue to be approximately $92 million, compared […]